Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Acutaas Chemicals Limited (NSE: ACUTAAS), ISIN INE00FF01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ACUTAAS last traded at ₹3268.95 (+1.74%), with a 52-week range of ₹1290.05 to ₹3735.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 32.66%, FIIs 21.61%, DIIs 19.56%, mutual funds 14.17%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.